US$ 21.21
glp-1 receptor agonist mechanism of action Glucagon-like peptide 1 agonists: cardiovascular benefits and mechanisms A Closer Look at the
Description
34 The trial had a total of 731 patients with a baseline mean A1C of 8.2% and a baseline total daily dose of insulin ranging from 56 to 62 units, depending on the treatment group

10.1056/NEJMoa1603827 7

Recuperato da: Thomsen M, Dencker D, Wrtwein G, Weikop P, Egecioglu E, Jerlhag E, et al

SGLT2is reduce oxidative stress by activating SIRT1/AMPK and inhibiting Akt/mTOR, thus collectively contributing to improved cellular energy efficiency, increased resistance to oxidative damage, and ultimately cardio- and renoprotection (reduced blood volume and blood pressure, promotion of diuresis and natriuresis, and glycosuria), especially beneficial in HF cases where excessive fluid can place additional strain on the heart [96,97]

There was even a lower risk of overall cancer in patients treated with albiglutide in the subgroup analysis (92)

The Microdose GLP-1 Protocol stays at $129 monthly regardless of dose adjustments
